(RGLS) Regulus Therapeutics complete technical analysis [charts+indicators] | Buy/Sell Regulus Therapeutics | (RGLS) share price targets
Complete technical analysis of Regulus Therapeutics (RGLS) by charts plus indicators, forecast predictions and share price targets for Regulus Therapeutics (RGLS)
Regulus Therapeutics trades in USA in Health Care sector.
Showing technical analysis as on 2024-07-03 View latest technical analysis
10 day averaged volume of Regulus Therapeutics is 2962320
| Date | Daily Closing Price | Open | High | Low | Volume |
| 03 Wed Jul 2024 | 1.80 | 1.75 | 1.82 | 1.71 | 0.126 times |
| 03 Wed Jul 2024 | 1.80 | 1.75 | 1.82 | 1.71 | 0.126 times |
| 02 Tue Jul 2024 | 1.76 | 1.85 | 1.93 | 1.76 | 0.225 times |
| 01 Mon Jul 2024 | 1.90 | 1.73 | 1.90 | 1.72 | 0.286 times |
| 28 Fri Jun 2024 | 1.79 | 2.00 | 2.00 | 1.66 | 2.737 times |
| 27 Thu Jun 2024 | 2.03 | 2.03 | 2.08 | 2.01 | 0.207 times |
| 26 Wed Jun 2024 | 2.04 | 2.13 | 2.13 | 1.92 | 0.313 times |
| 25 Tue Jun 2024 | 2.14 | 2.05 | 2.30 | 2.01 | 0.662 times |
| 24 Mon Jun 2024 | 2.05 | 2.05 | 2.40 | 1.95 | 3.706 times |
| 21 Fri Jun 2024 | 2.51 | 2.57 | 2.59 | 2.37 | 1.42 times |
My analysis of stock is bearish for shortterm, but trade for tomorrow is selective. Take a sell trade only if stock stays below 1.9, but if it comes above 1.9, then a intra day buy could be more profitable.
If you take a sell trade below 1.9, then use 1.9 as stoploss and 1.6 as target. However if you take a buy trade in stock , then use 1.9 as stoploss and 2.2 as target.
Share price targets for Regulus Therapeutics (RGLS)
| Target Type | Value |
| Downside Target | 1.32 |
| Downside Target | 1.66 |
| Downside Target | 1.71 |
| Downside Target | 1.79 |
| Upside Target | 1.93 |
| Upside Target | 2.09 |
| Upside Target | 2.32 |
| Upside Target | 2.40 |
| Upside Target | 2.51 |
| Upside Target | 2.59 |
| Upside Target | 2.90 |
| Upside Target | 2.91 |
| Upside Target | 3.79 |
Intraday share price targets for Regulus Therapeutics (RGLS)
| Target Type | Value |
| Downside Intraday Target | 1.73 |
| Downside Intraday Target | 1.67 |
| Upside Intraday Target | 1.84 |
| Upside Intraday Target | 1.89 |
| Downside Intraday Target | 1.78 |
Weekly technical analysis of Regulus Therapeutics (RGLS)
| Date | Weekly Closing Price | Open | High | Low | Volume |
| 03 Wed Jul 2024 | 1.80 | 1.75 | 1.82 | 1.71 | 0.198 times |
| 03 Wed Jul 2024 | 1.80 | 1.73 | 1.93 | 1.71 | 0.084 times |
| 28 Fri Jun 2024 | 1.79 | 2.05 | 2.40 | 1.66 | 3.761 times |
| 21 Fri Jun 2024 | 2.51 | 2.38 | 2.59 | 2.32 | 4.992 times |
| 18 Tue Jun 2024 | 2.48 | 2.42 | 2.51 | 2.32 | 0.55 times |
Price has moved down this week, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming weeks.
Monthly technical analysis of Regulus Therapeutics (RGLS)
| Date | Monthly Closing Price | Open | High | Low | Volume |
| 03 Wed Jul 2024 | 1.80 | 1.73 | 1.93 | 1.71 | 0.067 times |
| 28 Fri Jun 2024 | 1.79 | 2.34 | 2.59 | 1.66 | 2.937 times |
| 31 Fri May 2024 | 2.29 | 2.30 | 2.90 | 1.79 | 1.719 times |
| 30 Tue Apr 2024 | 2.30 | 2.90 | 2.91 | 2.09 | 0.036 times |
Scroll below to view daily charts
Price has moved up this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Regulus Therapeutics (RGLS)
Price action analysis of Regulus Therapeutics ( (RGLS) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Regulus Therapeutics ( (RGLS) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Regulus Therapeutics ( (RGLS) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Regulus Therapeutics ( (RGLS) ) based on a mid to longer term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Regulus Therapeutics stock for short term is SELL. Signal strength is Weak and stock is losing momentum.
MACD generated a SELL signal for Regulus Therapeutics in short term and the sell signal is strong.
Regulus Therapeutics Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are getting stronger in this stock.
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down
CCI has generated a SELL signal for Regulus Therapeutics in short term
RSI is generating a SELL signal in short term but selling is losing momentum.
MRSI is in positive zone. This is a BUY zone
Stock of Regulus Therapeutics is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 2.03 and Regulus Therapeutics (RGLS) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Regulus Therapeutics (RGLS) stock. Volume based technical analysis of Regulus Therapeutics (RGLS) stock is negative.
Regulus Therapeutics Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Regulus Therapeutics ( (RGLS) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Regulus Therapeutics ( (RGLS) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Regulus Therapeutics ( (RGLS) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Regulus Therapeutics ( (RGLS) ) based on a mid to longer term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Regulus Therapeutics stock for short term is SELL. Signal strength is Weak and stock is losing momentum.
MACD generated a SELL signal for Regulus Therapeutics in short term and the sell signal is strong.
Regulus Therapeutics Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are getting stronger in this stock.
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down
CCI has generated a SELL signal for Regulus Therapeutics in short term
RSI is generating a SELL signal in short term but selling is losing momentum.
MRSI is in positive zone. This is a BUY zone
Stock of Regulus Therapeutics is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 2.03 and Regulus Therapeutics (RGLS) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Regulus Therapeutics (RGLS) stock. Volume based technical analysis of Regulus Therapeutics (RGLS) stock is negative.
Regulus Therapeutics Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.